This is an early safety study testing a new type of vaccine for people with a common form of breast cancer (estrogen receptor-positive). The vaccine uses small pieces of protein (peptides) from the cancer to try to teach the body's immune system to recognize and fight the disease…
Phase: PHASE1 • Sponsor: Herbert Lyerly • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC